Search

Author/Creator Rea, Daniel

1. 6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial. Issue 10191 (29th June 2019)

Authors:
Earl, Helena M; Hiller, Louise; Vallier, Anne-Laure; Loi, Shrushma; McAdam, Karen; Hughes-Davies, Luke; Harnett, Adrian N; Ah-See, Mei-Lin; Simcock, Richard; Rea, Daniel; Raj, Sanjay; Woodings, Pamela; Harries, Mark; Howe, Donna; Raynes, Kerry; Higgins, Helen B; Wilcox, Maggie; Plummer, Chris; Ma...
Journal:
Lancet
Issue:
Volume 393:Issue 10191(2019)
Page Start:
2599
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial. Issue 10191 (29th June 2019)

Authors:
Earl, Helena M; Hiller, Louise; Vallier, Anne-Laure; Loi, Shrushma; McAdam, Karen; Hughes-Davies, Luke; Harnett, Adrian N; Ah-See, Mei-Lin; Simcock, Richard; Rea, Daniel; Raj, Sanjay; Woodings, Pamela; Harries, Mark; Howe, Donna; Raynes, Kerry; Higgins, Helen B; Wilcox, Maggie; Plummer, Chris; Ma...
Journal:
Lancet
Issue:
Volume 393:Issue 10191(2019)
Page Start:
2599
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Adjuvant tamoxifen and exemestane in women with postmenopausal early breast cancer (TEAM): 10-year follow-up of a multicentre, open-label, randomised, phase 3 trial. Issue 9 (September 2017)

Authors:
Derks, Marloes G M; Blok, Erik J; Seynaeve, Caroline; Nortier, Johan W R; Kranenbarg, Elma Meershoek-Klein; Liefers, Gerrit-Jan; Putter, Hein; Kroep, Judith R; Rea, Daniel; Hasenburg, Annette; Markopoulos, Christos; Paridaens, Robert; Smeets, Jan B E; Dirix, Luc Y; van de Velde, Cornelis J H
Journal:
Lancet oncology
Issue:
Volume 18:Issue 9(2017:Sep.)
Page Start:
1211
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials. Issue 3 (March 2022)

Authors:
Bradley, Rosie; Braybrooke, Jeremy; Gray, Richard; Hills, Robert K; Liu, Zulian; Pan, Hongchao; Peto, Richard; Dodwell, David; McGale, Paul; Taylor, Carolyn; Francis, Prudence A; Gnant, Michael; Perrone, Francesco; Regan, Meredith M; Berry, Richard; Boddington, Clare; Clarke, Mike; Davies, Christ...
Journal:
Lancet oncology
Issue:
Volume 23:Issue 3(2022)
Page Start:
382
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Circulating tumour DNA analysis to direct therapy in advanced breast cancer (plasmaMATCH): a multicentre, multicohort, phase 2a, platform trial. Issue 10 (October 2020)

Authors:
Turner, Nicholas C; Kingston, Belinda; Kilburn, Lucy S; Kernaghan, Sarah; Wardley, Andrew M; Macpherson, Iain R; Baird, Richard D; Roylance, Rebecca; Stephens, Peter; Oikonomidou, Olga; Braybrooke, Jeremy P; Tuthill, Mark; Abraham, Jacinta; Winter, Matthew C; Bye, Hannah; Hubank, Michael; Gevensl...
Journal:
Lancet oncology
Issue:
Volume 21:Issue 10(2020)
Page Start:
1296
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Efficacy of neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin, and cyclophosphamide, for women with HER2-negative early breast cancer (ARTemis): an open-label, randomised, phase 3 trial. Issue 6 (June 2015)

Authors:
Earl, Helena M; Hiller, Louise; Dunn, Janet A; Blenkinsop, Clare; Grybowicz, Louise; Vallier, Anne-Laure; Abraham, Jean; Thomas, Jeremy; Provenzano, Elena; Hughes-Davies, Luke; Gounaris, Ioannis; McAdam, Karen; Chan, Stephen; Ahmad, Rizvana; Hickish, Tamas; Houston, Stephen; Rea, Daniel; Bartlett...
Journal:
Lancet oncology
Issue:
Volume 16:Issue 6(2015:Jun.)
Page Start:
656
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Elderly Postmenopausal Patients With Breast Cancer Are at Increased Risk for Distant Recurrence: A Tamoxifen Exemestane Adjuvant Multinational Study Analysis. (20th December 2012)

Authors:
van de Water, Willemien; Seynaeve, Caroline; Bastiaannet, Esther; Markopoulos, Christos; Jones, Steve E.; Rea, Daniel; Hasenburg, Annette; Putter, Hein; Hille, Elysée T.M.; Paridaens, Robert; de Craen, Anton J.M.; Westendorp, Rudi G.J.; van de Velde, Cornelis J.H.; Liefers, Gerrit‐Jan
Journal:
Oncologist
Issue:
Volume 18:Number 1(2013)
Page Start:
8
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials. Issue 10179 (6th April 2019)

Authors:
Gray, Richard; Bradley, Rosie; Braybrooke, Jeremy; Liu, Zulian; Peto, Richard; Davies, Lucy; Dodwell, David; McGale, Paul; Pan, Hongchao; Taylor, Carolyn; Barlow, William; Bliss, Judith; Bruzzi, Paolo; Cameron, David; Fountzilas, George; Loibl, Sibylle; Mackey, John; Martin, Miguel; Del Mastro, L...
Journal:
Lancet
Issue:
Volume 393:Issue 10179(2019)
Page Start:
1440
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗